Replies to post #43195 on Medizone Intl. (fka MZEIQ)

[BenK]

Your points are well taken, I wasn't at the AGM so I can't speak to the takeaways of those who attended.

The point of my post was to find out exactly where the assumption of "trials in January" started. Now I know.

Getting sidetracked, as others have, into my past statements is a distraction.

I think you and I have spoken enough to make it clear that neither one of us excuses poor communication, which has been a problem for many, many years. The only reason I have identified this as an issue is in contrast to accusations of flat-out lies on the part of management, which I think are inaccurate, and more importantly, paint a very negative picture of the Company for potential investors.

As I said clearly before, we need younger, more experienced management to step in; everyone, IMO including present management, recognizes this, and it's a question of the pieces falling into place.... and us not falling apart.

[never-say-die]

Face reality.

Marshall has what he wants. Salaries for the gang guaranteed for a couple of years and the ability to dip into the reserve stock piggy bank whenever he wants to offset the dilution the rest of us must live with.

He could care less about communicating with ordinary shareholders. The group that finances him doesn't seem to care if this company ever makes a dime. For some unknown reason they continue to feed him despite overwhelming evidence of his incompetence.

All the hype about ASure so far is just that...hype.

I fully expect to hear nothing about hospital trials for the foreseeable future. The next time they announce anything it probable will be something like a new distributorship in Iceland.

Medizone is one weird little company.